Microprofit Biotech Shines at Medlab Middle East 2024 in Dubai

From February 5th to 8th, 2024, the Medlab Middle East Exhibition took place at the Dubai World Trade Centre. As one of the world’s most renowned and specialized platforms for medical laboratory instruments and diagnostic equipment, the event featured 15,000 square meters of exhibition space. Representatives from over 40 countries, 900+ exhibitors, and more than 30,000 attendees gathered to witness the latest innovations and cutting-edge technologies in the medical laboratory and diagnostics industry. The event provided a unique opportunity for interaction and networking with leading companies and professionals, offering a chance to explore the latest advancements and discuss future trends in healthcare technology.

As a key exhibitor in the in vitro diagnostics (IVD) field, Microprofit Biotech showcased its fluorecare FIA Quantitative POCT Platform and Respiratory Virus Rapid Test Solution. The Microprofit Biotech team warmly welcomed representatives, distributors, doctors, and scholars from around the world. Visitors were given detailed demonstrations of product usage, gaining a deeper understanding of the features and applications of Microprofit Biotech's innovative solutions.

With over 14 years of experience in IVD research and development, Microprofit Biotech has consistently pursued independent innovation, breaking through numerous technical barriers and overcoming significant challenges. To date, the company holds over 40 invention patents and has obtained more than 150 CE certifications. Backed by strong R&D capabilities and exceptional product quality, Microprofit Biotech has established partnerships in over 100 countries and regions worldwide.

We extend our heartfelt thanks to all the visitors who stopped by our booth. The event was a resounding success, filled with valuable insights and connections!